FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Fulgent Genetics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$20.10+0.29 (+1.46%)
Close on Oct 19, 2026
- Market cap
- $562.90M
- P/E (TTM)
- –
- Dividend yield
- –
Fulgent Genetics, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Services | $322.22M | $283.47M | $289.21M | $618.97M | $992.58M | – | – | – | – | – | 99.9% | +13.7% |
| Therapeutic Development | $447.00K | $0 | $0 | $0 | $0 | – | – | – | – | – | 0.1% | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Services | -$7.21M | -$4.91M | -$16.86M | $179.34M | $675.95M | – | – | – | – | – | +46.8% |
| Therapeutic Development | -$19.85M | -$16.56M | -$7.67M | -$816.00K | $0 | – | – | – | – | – | +19.8% |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $296.55M | $259.13M | $268.98M | $603.15M | $978.98M | $415.33M | $25.01M | $12.58M | $9.02M | $8.26M | 91.9% | +14.4% |
| Foreign | $26.12M | $24.34M | $20.24M | $15.82M | $13.61M | $6.38M | $7.51M | – | – | – | 8.1% | +7.3% |
| Other countries | $13.21M | $11.70M | $8.79M | $6.88M | – | $4.65M | $5.27M | $4.79M | $3.00M | $2.98M | 4.1% | +12.9% |
| China | $12.91M | $12.64M | $11.45M | $8.94M | – | – | – | $109.00K | $2.61M | $3.24M | 4.0% | +2.1% |
| Canada | – | – | – | – | – | $1.73M | $2.25M | $3.98M | $4.09M | $3.80M | – | – |
From the segment and revenue-disaggregation notes of Fulgent Genetics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.